Authors : James Akomeah Yeboah

Volume/Issue : Volume 9 - 2024, Issue 8 - August

Google Scholar : https://tinyurl.com/2bvu9rzp

Scribd : https://tinyurl.com/bdept6yt

DOI : https://doi.org/10.38124/ijisrt/IJISRT24AUG1701

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Abstract : Acemannan is said to be the biologically active substance in aloe vera (Aloe barbadensis). Many producers of aloe products utilize inadequate production and extraction methods, resulting in aloe products that contain little or no acemannan. This article outlines a systematic procedure for extracting the bioactive polysaccharide compound from the aloe plant. This paper also provides a description of the physical distinctive features of acemannan. The study also emphasized the determination of physical properties, such as the pKa and Log P values, of acemannan. The physical characteristics were used to evaluate the bioavailability and hydrophilicity of this chemical. The primary approach used to acquire these physical characteristics involves the extraction of acemannan from aloe vera, the creation of phosphate buffer with varying pH levels, the separation of acemannan between chloroform and buffer using the shake flask technique, and the utilization of spectrophotometric analysis. Chloroform was used as a representation of the lipid membrane in the experiment, whereas phosphate buffer was utilized to symbolize the blood. A buffer solution was used to maintain a steady pH at a desired value. The acemannan compound had a pKa value of 4.82 at a pH of 3.45, indicating its acidity. Additionally, the Log P value (chloroform/buffer) was determined to be -3.282, indicating its hydrophobicity. Thus, it was deduced that acemannan exhibited hydrophilic properties throughout the gastrointestinal system.

References :

1. AAPS NEWSMAGAZINE, (2007). Ionization Constant (pKa) And Partition Coefficient (Octanol-Water System). p 1-19.
2. Aniade L. N., (2008). Current Methodology for the Assessment of ADME Properties on Drug Candidate Molecules. p 97-110.
3. Ashish, S. K., (2007). Determination Of pKa’s Of Hydroxamic Acids by Nucleophilic Substitution Reaction. Indian Journal of Chemistry. p 1630-1634.
4. Donkor M-D., (2011). Principles of medicinal chemistry. Ghana. Faculty of Applied Sciences, Department Of Applied Chemistry And Biochemistry Navrongo, University For Development Studies, (Unpublished).
5. Hamman, J. H., and Viljoen, A. M., (2008). Use of Aloe vera for increasing the bioavailability of poorly absorbable drugs. Patent application 01542.
6. Harris, C., Pierce. K., King. G., Yates. K. M. and Hall, J., (1991). Efficacy of acemannan in treatment of canine and feline spontaneous neoplasm. p 207- 213.
7. Jane Davis, (1997). Aloe Vera a mission discovered. p 1-2.
8. Johnson. A. R, White A.C., and Mcanalley. B. H., (1989). Comparison of common topical agents for wound treatment: Cytotoxicity for human fibroblast in culture. Wounds: a compendium of clinical Research and Practice, p 18-19.
9. Kaliszan, T., (2001). ‘Gradient HPLC in the determination of drug lipophilicity and acidity, p 1465-1475.
10. Kev, A. N., and Can, A., (1999). Separation and some properties of Aloe vera leaf pulp lectins. p 13 and 489.
11. Lee, J. K., Lee M. K., Yun Y. P., Kim, Y., and Lee, C. K., (2001). Acemannan purified from Aloe vera induces phenotypic and functional maturation of immature dendritic cells Int. Immunopharmacol.
12. Mcanalley, B. H., (1989). Patent No. WO 89/06539. U.S.A.
13. McDaniel, H. R., (1987). In vitro studies on polymannoacetate (Carrisyn) for antiviral effect. American Society of Clinical Pathologists Scientific Assembly, New Orleans.
14. Ràfols, C., Bosch, E., Ruiz R., Box, K. J., Reis, M., (2012). Acidity and Hydrophobicity of Several New Potential Antitubercular Drugs: Benzimidazole Derivatives. J. Chem. Eng. Data. p 330–338.
15. Sanjivanjit, K., (2010). Lipophilicity descriptors: Understanding when to use Log P and log D advanced chemistry development. p 1-4. Canada
16. Sarfaraz, K. N., (2007). ‘Handbook of reformulation Chemical, Biological, and Botanical Drugs’ Infomation Health care U.S.A. p 1-439.
17. Savva, M., (2010). Partition Phenomenon. Long Island University, college of Pharmacy and health sciences, U.S.A.
18. Singer, J., (1993). A randomized placebo-controlled trial of oral acemennan as an adjunctive to anti-retroviral therapy in advanced HIV disease. Ninth International AIDS Conference. p 28-53.
19. Sung, C. K., (2002). The history of Aloe. In Y. I. Park, & S. K. Lee, NEW PERSPECTIVE ON ALOE. p 7-13.
20. Turner C. E., Williamson D. A, Stroud P. A., Tally D. J., (2004). Evaluation and comparison of commercially available Aloe Vera L. products using size exclusion chromatography with refractive index and Multi-angle laser light scattering detection. International Immunopharmacology. p 1727-1737.
21. Yakugaku, Z., (2003). Anti inflammatory constituents, aloesin and aloemannan in Aloe species. p 1-4.
22. Yulia, B., (2008). Aloe and your heath. p 1-25.